The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT00893854
• Date of registration: 04/05/2009
• Primary sponsor: Shaheed Beheshti Medical University
• Public title: The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
• Scientific title: The Comparison Between the Therapeutic Affect of Intravitreal Diclophenac and Triamcinolone in Persistent Uveitic Cystoids Macular Edema
• Date of first enrolment: February 2009
• Recruitment status: Recruiting
• URL: http://clinicaltrials.gov/show/NCT00893854
• Study type: Interventional
• Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Countries of recruitment

Iran, Islamic Republic of

Contacts

• Name: Masoud Soheilian, MD

Key inclusion & exclusion criteria

Inclusion Criteria:

- cystoids macular edema which is diagnosed by OCT and flurocein angiography

- 5/200 < Visual acuity < 20/50

- resistance to routine treatment (oral treatment, periocular injection)

Exclusion Criteria:

- history of retinal disease cause macular edema like diabetes

- arterial occlusion

- monocular patients

- patients candidate for intra-ocular operation

- history of glaucoma or ocular hypertension

- any cataract that would interfere with OCT



Age minimum: N/A
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Cystoid Macular Edema

Uveitis

Intervention(s)

Drug: Diclophenac

Drug: Triamcinolone

Secondary ID(s)

8727

Source(s) of Monetary Support

Please refer to primary and secondary sponsors